ARS Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 10.86 M | $109.15 M | 0.00% | 11.04% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 8.29 M | $83.30 M | 0.00% | 8.43% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 7.50 M | $75.41 M | -22.84% | 7.63% |
| BLACKROCK, INC. | 11/12/2025 | 4.83 M | $48.55 M | 9.22% | 4.91% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 4.50 M | $45.23 M | 247.52% | 4.57% |
| SR ONE CAPITAL MANAGEMENT, LP | 11/12/2025 | 4.01 M | $40.33 M | 0.00% | 4.08% |
| VANGUARD GROUP INC | 11/07/2025 | 3.50 M | $35.18 M | 7.28% | 3.56% |
| ABRDN PLC | 11/07/2025 | 3.10 M | $31.13 M | 106.11% | 3.15% |
| STATE STREET CORP | 11/14/2025 | 2.90 M | $29.10 M | 31.93% | 2.94% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 2.64 M | $26.55 M | -30.94% | 2.69% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 2.40 M | $24.10 M | 31.13% | 2.44% |
| CASDIN CAPITAL, LLC | 11/14/2025 | 1.60 M | $16.08 M | 100.00% | 1.63% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.59 M | $15.94 M | -29.26% | 1.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.51 M | $15.13 M | 12.16% | 1.53% |
| SOUTHPOINT CAPITAL ADVISORS LP | 11/14/2025 | 1.50 M | $15.08 M | -12.23% | 1.53% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.33 M | $13.32 M | -9.46% | 1.35% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 1.30 M | $13.10 M | 0.00% | 1.33% |
| BAMCO INC /NY/ | 11/14/2025 | 1.27 M | $12.75 M | 3,071.33% | 1.29% |
| JANNEY MONTGOMERY SCOTT LLC | 10/27/2025 | 1.21 M | $12.19 M | 105.10% | 1.23% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 1.03 M | $10.40 M | 100.00% | 1.05% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 976.51 K | $9.81 M | 100.00% | 0.99% |
| LEVIN CAPITAL STRATEGIES, L.P. | 11/07/2025 | 764.29 K | $7.68 M | 164.33% | 0.78% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 756.35 K | $7.60 M | 12.32% | 0.77% |
| FMR LLC | 11/13/2025 | 742.51 K | $7.46 M | -52.62% | 0.75% |
| MORGAN STANLEY | 11/14/2025 | 700.41 K | $7.04 M | 82.58% | 0.71% |
| NEXTECH INVEST, LTD. | 11/14/2025 | 660.70 K | $6.64 M | -10.92% | 0.67% |
| UBS GROUP AG | 11/13/2025 | 659.89 K | $6.63 M | -23.88% | 0.67% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 631.72 K | $6.35 M | 100.00% | 0.64% |
| K2 PRINCIPAL FUND, L.P. | 11/13/2025 | 621.81 K | $6.25 M | 96.08% | 0.63% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 562.40 K | $5.65 M | 100.00% | 0.57% |
| NORTHERN TRUST CORP | 11/14/2025 | 531.50 K | $5.34 M | 9.59% | 0.54% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 520.76 K | $5.23 M | 17.76% | 0.53% |
| CENTERBOOK PARTNERS LP | 11/07/2025 | 512.37 K | $5.15 M | 100.00% | 0.52% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 390.09 K | $3.92 M | 34.47% | 0.40% |
| EMPIRE LIFE INVESTMENTS INC. | 11/12/2025 | 355.69 K | $3.57 M | 100.00% | 0.36% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 352.94 K | $3.55 M | 3.77% | 0.36% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 335.15 K | $3.37 M | 2.92% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 285.40 K | $2.87 M | 128.87% | 0.29% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 272.03 K | $2.73 M | -16.39% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 260.30 K | $2.62 M | 340.44% | 0.26% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 246.17 K | $2.47 M | -25.19% | 0.25% |
| JANE STREET GROUP, LLC | 11/14/2025 | 242.04 K | $2.43 M | 100.00% | 0.25% |
| BARCLAYS PLC | 11/12/2025 | 228.57 K | $2.30 M | -63.27% | 0.23% |
| LISANTI CAPITAL GROWTH, LLC | 11/04/2025 | 211.19 K | $2.12 M | -49.73% | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 204.60 K | $2.06 M | 100.00% | 0.21% |
| FAS WEALTH PARTNERS, INC. | 10/29/2025 | 200.62 K | $2.02 M | 34.50% | 0.20% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 200.00 K | $2.01 M | 100.00% | 0.20% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 199.15 K | $2.00 M | 100.00% | 0.20% |
| MARSHALL WACE, LLP | 11/13/2025 | 197.32 K | $1.98 M | 394.36% | 0.20% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 186.73 K | $1.82 M | -20.49% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 243 institutional investors and hedge funds held shares of ARS Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.86 M
ORBIMED ADVISORS LLC: 8.29 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 7.5 M
BlackRock, Inc.: 4.83 M
Rubric Capital Management LP: 4.5 M
SR ONE CAPITAL MANAGEMENT, LP: 4.01 M
85.03% of ARS Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 89.51 M shares in the last 24 months. This purchase volume represents approximately $922.84 M in transactions.